Table 2.
Variable | Non‐healing group [n = 43 (%)] | Healing group [n = 202 (%)] | P | |
---|---|---|---|---|
Completed the follow‐up [n = 185 (%)] | Lost to follow‐up [n = 17 (%)] | |||
Male | 23 | 119 | 13 | 0·143 |
Age (years) | 67·9 ± 10·14 | 69·39 ± 9·22 | 71·24 ± 9·31 | 0·314 |
Duration of DM (years) | 14·14 ± 6·61 | 12·49 ± 7·45 | 12·82 ± 7·40 | 0·188 |
Duration of diabetic foot ulcer before hospitalisation (weeks) | 8·35 ± 1·19 | 7·51 ± 1·62 | 7·46 ± 1·69 | 0·137 |
Body mass index | 24·93 ± 3·23 | 23·82 ± 2·45 | 23·72 ± 2·74 | 0·012 |
Family history of diabetes | 20 (46·5) | 63 (34·1) | 6 (35·3) | 0·126 |
Smoking history | 23 (53·5) | 74 (40·0) | 9 (52·9) | 0·136 |
Drinking history | 28 (65·1) | 93 (50·3) | 10 (58·8) | 0·092 |
Retinopathy | 26 (60·5) | 105 (56·8) | 11 (64·7) | 0·714 |
Cerebrovascular disease | 15 (34·9) | 69 (37·3) | 6 (35·3) | 0·728 |
Hyperlipidaemia | 20 (46·5) | 87 (47·0) | 8 (47·1) | 0·951 |
Hypertension | 25 (58·1) | 104 (56·2) | 9 (52·9) | 0·792 |
Chronic ischaemic heart diseases | 30 (69·8) | 125 (67·6) | 11 (64·7) | 0·756 |
Diabetic nephropathy | 34 (79·1) | 88 (47·6) | 3 (17·6) | 0·000 |
Peripheral neuropathy | 26 (60·5) | 136 (73·5) | 11 (64·7) | 0·108 |
HbA1c (%) | 12·24 ± 2·12 | 9·91 ± 2·78 | 10·95 ± 2·98 | 0·000 |
Peripheral arterial disease | 39 (90·7) | 158 (85·4) | 14 (82·4) | 0·339 |
Critical limb ischaemia | 33 (76·7) | 78 (42·2) | 5 (29·4) | 0·000 |
Infection | 35 (81·4) | 116 (62·7) | 13 (76·5) | 0·026 |
Insulin therapy | 26 (60·5) | 121 (65·4) | 12 (70·6) | 0·621 |